COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

CEO

Mr. Kabir Kumar Nath M.A., M.B.A.

Karyawan

166

Negara

ISIN

US20451W1018

Pencatatan

0 Comments

Bagikan pendapatmu

FAQ

Berapa harga saham Compass Pathways hari ini?▼

Harga saat ini dari CMPS.BOATS adalah $6.41 USD — turun sebesar -4.9% dalam 24 jam terakhir. Pantau kinerja harga saham Compass Pathways lebih dekat di grafik.

Apa simbol saham Compass Pathways?▼

Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Compass Pathways diperdagangkan dengan simbol CMPS.BOATS.

Berapa pendapatan Compass Pathways tahun lalu?▼

Pendapatan Compass Pathways tahun lalu berjumlah 0 USD.

Berapa pendapatan bersih Compass Pathways tahun lalu?▼

Pendapatan bersih CMPS.BOATS untuk tahun lalu adalah -310.24M USD.

Berapa jumlah karyawan Compass Pathways?▼

Per Februari 03, 2026, perusahaan memiliki 166 karyawan.

Compass Pathways berada di sektor apa?▼

Compass Pathways beroperasi di sektor Health Care.

Kapan Compass Pathways menyelesaikan split saham?▼

Compass Pathways belum melakukan split saham baru-baru ini.

Di mana kantor pusat Compass Pathways?▼

Kantor pusat Compass Pathways berlokasi di London, GB.